There were 1,778 press releases posted in the last 24 hours and 403,652 in the last 365 days.

Trifecta Pharmaceuticals USA’s topical analgesic Rhuli Gel returns to market by popular demand

A popular topical anti-itch relief for minor skin irritation

FORT LAUDERDALE, FLORIDA, UNITED STATES, February 6, 2018 /EINPresswire.com/ -- TRIFECTA PHARMACEUTICALS, a leading developer, manufacturer and distributor of specialty OTC topical ointments, creams and gels, has re-introduced the popular topical analgesic, Rhuli Gel, to the market.

Rhuli Gel is primarily used to treat the symptoms of insect stings and bites, as well as skin irritation caused by contact with poison ivy, oak and sumac. Known and loved as a household first-aid staple in the 80s and 90s, Rhuli Gel became popular with families across the United States for its fast action and non-drip formula. Rhuli Gel was later purchased, renamed and re-formulated by Johnson & Johnson.

Trifecta Pharmaceuticals USA Chief Executive, Mr. Greg Brondou, said, “We are delighted to be bringing Rhuli Gel back to the market. We’ve been reminded of its popularity over the years by loyal customers who remember it as a trusted first aid product, and we know that both new and old customers will be excited to see it on the shelves again.”

Rhuli Gel is now available on Amazon.com, at local independent pharmacies and via healthcare distributors nationwide.

Trifecta Pharmaceuticals’ resident Registered Pharmacist, Mr. Svet Milic, said, “People have been asking about Rhuli Gel at our pharmacy for years and it was time to bring it back. Our formulation will remain the same, with a combination of cooling menthol and pain-relieving camphor, to soothe the irritated area.”

-ENDS-

About Trifecta Pharmaceuticals USA

Trifecta Pharmaceuticals is a leading developer, manufacturer and distributor of specialty over-the-counter (OTC) topical ointments, creams, gels and oral rehydration salts. The company prides itself on delivering the highest standards in quality, value and service to its customers across the United States.

In addition to its US commercial operations, Trifecta Pharmaceuticals works closely with international NGOs, charitable organizations and government agencies as the preferred provider of generic pharmaceuticals, medical supplies and topical applications.

Trifecta Pharmaceuticals products are available at pharmacies, Amazon.com and via healthcare distributors nationwide. For more information, please visit www.trifecta-pharma.com.

Media and product information enquiries

SALES DEPARTMENT
Trifecta Pharmaceuticals USA
www.trifecta-pharma.com
www.rhuligel.com
info@trifecta-pharma.com
1 888 296 9067

MEDIA AND PUBLIC RELATIONS
Catherine Corcoran
Trifecta Pharmaceuticals USA
813 895 4575

Trifecta Pharmaceuticals USA
Trifecta Pharmaceuticals USA
1 888 296 9067
email us here